| Literature DB >> 28768726 |
Ching-Wen Chen1,2,3, Rohit Mittal1, Nathan J Klingensmith1, Eileen M Burd4, Cox Terhorst5, Greg S Martin6, Craig M Coopersmith1,3, Mandy L Ford7,2.
Abstract
Sepsis is a leading cause of death in the United States, but the mechanisms underlying sepsis-induced immune dysregulation remain poorly understood. 2B4 (CD244, SLAM4) is a cosignaling molecule expressed predominantly on NK cells and memory CD8+ T cells that has been shown to regulate T cell function in models of viral infection and autoimmunity. In this article, we show that 2B4 signaling mediates sepsis lymphocyte dysfunction and mortality. 2B4 expression is increased on CD4+ T cells in septic animals and human patients at early time points. Importantly, genetic loss or pharmacologic inhibition of 2B4 significantly increased survival in a murine cecal ligation and puncture model. Further, CD4-specific conditional knockouts showed that 2B4 functions on CD4+ T cell populations in a cell-intrinsic manner and modulates adaptive and innate immune responses during sepsis. Our results illuminate a novel role for 2B4 coinhibitory signaling on CD4+ T cells in mediating immune dysregulation.Entities:
Mesh:
Substances:
Year: 2017 PMID: 28768726 PMCID: PMC5587400 DOI: 10.4049/jimmunol.1700375
Source DB: PubMed Journal: J Immunol ISSN: 0022-1767 Impact factor: 5.422